应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
VRTX 福泰制药
交易中 04-26 13:01:21 EDT
399.55
+1.85
+0.46%
最高
399.62
最低
393.49
成交量
23.19万
今开
393.52
昨收
397.70
日振幅
1.54%
总市值
1,033亿
流通市值
1,030亿
总股本
2.58亿
成交额
9,209万
换手率
0.09%
流通股本
2.58亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
福泰制药跌0.27% 股价跌破400美元大关
自选股智能写手 · 04-25 21:34
福泰制药跌0.27% 股价跌破400美元大关
VERTEX 和 TREEFROG THERAPEUTICS 宣布签订许可协议并开展合作
美通社 · 04-25 00:58
VERTEX 和 TREEFROG THERAPEUTICS 宣布签订许可协议并开展合作
BUZZ-Vertex 因计划发行可转换债券而下跌
Reuters · 04-23
BUZZ-Vertex 因计划发行可转换债券而下跌
Vertex, Inc.盘中异动 股价大跌6.57%
自选股智能写手 · 04-23
Vertex, Inc.盘中异动 股价大跌6.57%
B of A Securities:维持Vertex(VERX.US)评级,由中性调整至中性评级, 目标价由40.00美元调整至34.00美元。
智通财经 · 04-23
B of A Securities:维持Vertex(VERX.US)评级,由中性调整至中性评级, 目标价由40.00美元调整至34.00美元。
BUZZ-Vertex 在宣布可转换债务交易和第一季度初步业绩后下跌
Reuters · 04-23
BUZZ-Vertex 在宣布可转换债务交易和第一季度初步业绩后下跌
福泰制药涨1.50% 股价突破400美元大关
自选股智能写手 · 04-22
福泰制药涨1.50% 股价突破400美元大关
十亿美元分子幻灭
阿基米德Biotech · 04-22
十亿美元分子幻灭
福泰制药涨0.86% 股价突破400美元大关
自选股智能写手 · 04-15
福泰制药涨0.86% 股价突破400美元大关
美股再现350亿元巨额并购!国内药企抢占IgA肾病药物黄金赛道
华夏时报 · 04-13
美股再现350亿元巨额并购!国内药企抢占IgA肾病药物黄金赛道
355亿巨额并购,IgA肾病赛道起风了
蓝鲸财经 · 04-12
355亿巨额并购,IgA肾病赛道起风了
隔夜美股全复盘(4.12)| 三大股指盘中持续走高,苹果、英伟达均涨超4%,据报苹果计划全面更新Mac产品线,搭载增强AI功能的M4芯片
格隆汇 · 04-12
隔夜美股全复盘(4.12)| 三大股指盘中持续走高,苹果、英伟达均涨超4%,据报苹果计划全面更新Mac产品线,搭载增强AI功能的M4芯片
福泰制药涨1.37% 股价突破400美元大关
自选股智能写手 · 04-11
福泰制药涨1.37% 股价突破400美元大关
快讯| 美股三大指数集体高开,道指涨0.17%,纳指涨0.42%。热门中概股开盘多数上涨,哔哩哔哩涨近3%,微博涨超2%,阿里巴巴涨超1%;Alpine Immune涨超36%,获福泰制药49亿美元收购。
腾讯自选股 · 04-11
快讯| 美股三大指数集体高开,道指涨0.17%,纳指涨0.42%。热门中概股开盘多数上涨,哔哩哔哩涨近3%,微博涨超2%,阿里巴巴涨超1%;Alpine Immune涨超36%,获福泰制药49亿美元收购。
354亿元!自免系统最大收购案诞生,市场空间广阔
证券时报e公司 · 04-11
354亿元!自免系统最大收购案诞生,市场空间广阔
Evercore ISI Group:上调Vertex Pharmaceuticals(VRTX.US)评级,由大市同步调整至优于大市评级, 目标价438.00美元。
智通财经 · 04-11
Evercore ISI Group:上调Vertex Pharmaceuticals(VRTX.US)评级,由大市同步调整至优于大市评级, 目标价438.00美元。
BUZZ-街景:Vertex斥资49亿美元收购Alpine Immune,扩大产品组合
Reuters · 04-11
BUZZ-街景:Vertex斥资49亿美元收购Alpine Immune,扩大产品组合
更新版 1-Vertex 制药公司将以 49 亿美元收购阿尔卑斯免疫科学公司
Reuters · 04-11
更新版 1-Vertex 制药公司将以 49 亿美元收购阿尔卑斯免疫科学公司
加载更多
公司概况
公司名称:
福泰制药
所属市场:
NASDAQ
上市日期:
--
主营业务:
Vertex Pharmaceuticals Incorporated成立于1989年,是一家全球性生物技术公司。公司致力于发现、开发、生产和商业化用于专业市场严重疾病的小分子药物。公司与一些世界上最大的制药公司、领先的非盈利性疾病研究机构及许多世界上最知名的学术机构都有合作关系。公司有两款产品:KALYDECO和INCIVEK。
发行价格:
--
{"stockData":{"symbol":"VRTX","market":"US","secType":"STK","nameCN":"福泰制药","latestPrice":399.545,"timestamp":1714150879137,"preClose":397.7,"halted":0,"volume":231854,"delay":0,"floatShares":257714825,"shares":258459343,"eps":13.89,"marketStatus":"交易中","marketStatusCode":2,"change":1.845,"latestTime":"04-26 13:01:21 EDT","open":393.52,"high":399.615,"low":393.49,"amount":92088483.51178,"amplitude":0.015401,"askPrice":399.66,"askSize":6,"bidPrice":399.44,"bidSize":6,"shortable":3,"etf":0,"ttmEps":13.89,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1714161600000},"adr":0,"adjPreClose":397.7,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":393.27,"preClose":397.7,"latestTime":"09:29 EDT","volume":1159,"amount":456042.58983,"timestamp":1714138199958},"postHourTrading":{"tag":"盘后","latestPrice":396.5,"preClose":397.7,"latestTime":"19:42 EDT","volume":35459,"amount":14101267.6801,"timestamp":1714088558178},"volumeRatio":0.39489},"requestUrl":"/m/hq/s/VRTX/","defaultTab":"news","newsList":[{"id":"2430289630","title":"福泰制药跌0.27% 股价跌破400美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2430289630","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430289630?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:34","pubTimestamp":1714052063,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时34分,福泰制药股票出现异动,股价快速跳水0.27%。截至发稿,该股报399.66美元/股,成交量2.9902万股,换手率0.01%,振幅1.05%。福泰制药股票所在的生物技术行业中,整体跌幅为0.73%。福泰制药公司简介:Vertex Pharmaceuticals 是一家发现和开发用于治疗严重疾病的小分子药物的全球生物技术公司。此外,Vertex 正在评估使用非阿片类药物治疗的针对急性和慢性疼痛的小分子抑制剂,以及 APOL1 介导的肾脏疾病的小分子抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252134247a55b36b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404252134247a55b36b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430246948","title":"VERTEX 和 TREEFROG THERAPEUTICS 宣布签订许可协议并开展合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2430246948","media":"美通社","top":-1,"share":"https://www.laohu8.com/m/news/2430246948?lang=zh_cn&edition=full","pubTime":"2024-04-25 00:58","pubTimestamp":1713977880,"startTime":"0","endTime":"0","summary":"VERTEX 和 TREEFROG THERAPEUTICS 宣布签订许可协议并开展合作以优化VERTEX的1 型糖尿病细胞治疗药物的生产 Vertex 已获得 TreeFrog 用于治疗 1 型糖尿病的 C-StemTM 制造技术的独家许可 TreeFrog 和 Vertex 将合作扩大完全分化、能产生胰岛素的胰岛细胞的生产规模 波士顿和法国波尔多2024年4月25日 /美通社/ -- Vertex Pharmaceuticals Incorporated和 TreeFrog Therapeutics 今天宣布,Vertex 已获得 TreeFrog 专利细胞制造技术 C-StemTM 的独家许可,以优化 Vertex 在 1 型糖尿病 细胞治疗药物方面的生产。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4393940_ZH93940_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2429004116","title":"BUZZ-Vertex 因计划发行可转换债券而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2429004116","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2429004116?lang=zh_cn&edition=full","pubTime":"2024-04-23 22:55","pubTimestamp":1713884137,"startTime":"0","endTime":"0","summary":" 4月23日 - ** 税务软件公司Vertex Inc 寻求融资,周二股价下跌6.2%,报28.18美元。** 该公司周一晚些时候宣布 非公开发行 2.5 亿美元的 5 年期可转换债券** 该公司计划将募集资金净额用于上限认购交易,其余用于营运资金/一般用途,包括资本支出、潜在收购和战略交易。** VERX 的市值约为 44 亿美元** 花旗集团将 VERX 评为 \"中性\",并将其预测值下调 2 美元至 32 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2429183061","title":"Vertex, Inc.盘中异动 股价大跌6.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429183061","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429183061?lang=zh_cn&edition=full","pubTime":"2024-04-23 21:31","pubTimestamp":1713879069,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日21时31分,Vertex, Inc.股票出现波动,股价大幅下跌6.57%。Vertex, Inc.股票所在的软件服务行业中,整体涨幅为0.60%。Vertex, Inc.公司简介:Vertex Inc是一家提供税务技术和服务的公司。Vertex为特定行业提供基于云和内部部署的解决方案,涵盖收入、销售、消费者使用、增值和工资等各个税种。该信息摘要如下:B of A Securities:维持Vertex评级,由中性调整至中性评级, 目标价由40.00美元调整至34.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232131098b4abe43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232131098b4abe43&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429193255","title":"B of A Securities:维持Vertex(VERX.US)评级,由中性调整至中性评级, 目标价由40.00美元调整至34.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2429193255","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429193255?lang=zh_cn&edition=full","pubTime":"2024-04-23 19:26","pubTimestamp":1713871566,"startTime":"0","endTime":"0","summary":"B of A Securities:维持Vertex(VERX.US)评级,由中性调整至中性评级, 目标价由40.00美元调整至34.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042319261087a5f6d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042319261087a5f6d1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429689901","title":"BUZZ-Vertex 在宣布可转换债务交易和第一季度初步业绩后下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2429689901","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2429689901?lang=zh_cn&edition=full","pubTime":"2024-04-23 05:07","pubTimestamp":1713820073,"startTime":"0","endTime":"0","summary":" 4月22日 - ** Vertex Inc 股价盘后下跌2.5%,报29.30美元,原因是税务软件提供商寻求融资并发布了第一季度初步财报** 该公司表示,将私下发行 2.5 亿美元的 5 年期可转换债券。** 今年以来股价上涨 11.5%,过去 12 个月上涨约 36** 今年 1 月,Vertex 在 的竞标中被汤森路透 击败,后者以约 7.89 亿美元的价格收购了瑞典电子发票和税务解决方案公司 Pagero。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2429978640","title":"福泰制药涨1.50% 股价突破400美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2429978640","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429978640?lang=zh_cn&edition=full","pubTime":"2024-04-22 22:57","pubTimestamp":1713797831,"startTime":"0","endTime":"0","summary":"北京时间2024年04月22日22时57分,福泰制药股票出现波动,股价快速拉升1.50%。截至发稿,该股报400.20美元/股,成交量19.1534万股,换手率0.07%,振幅0.99%。福泰制药股票所在的生物技术行业中,整体涨幅为1.17%。福泰制药公司简介:Vertex Pharmaceuticals 是一家发现和开发用于治疗严重疾病的小分子药物的全球生物技术公司。此外,Vertex 正在评估使用非阿片类药物治疗的针对急性和慢性疼痛的小分子抑制剂,以及 APOL1 介导的肾脏疾病的小分子抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042222571287e82885&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042222571287e82885&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429958393","title":"十亿美元分子幻灭","url":"https://stock-news.laohu8.com/highlight/detail?id=2429958393","media":"阿基米德Biotech","top":-1,"share":"https://www.laohu8.com/m/news/2429958393?lang=zh_cn&edition=full","pubTime":"2024-04-22 00:25","pubTimestamp":1713716706,"startTime":"0","endTime":"0","summary":"每个理想主义的年代,人们只需要一本书、一场爱情,即可奔赴远方。记录福泰制药(Vertex)传奇创业史的《十亿美元分子》,在中国出版适逢创新药的初起年代,Biotech的海归科学家和热血青年人手一本,都憧憬着美好的未来。现在,理想基本被浇灭了。福泰制药最初尝试通过解析FK-506的靶点蛋白FKBP来设计选择性更强的靶向分子...","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/OPpZWfRVbFka8zOm1XihGlrdGPgqIvStiG5NmK5DN_xiEAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OPpZWfRVbFka8zOm1XihGlrdGPgqIvStiG5NmK5DN_xiEAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20240422A0044C00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20240422A0044C00","is_publish_highlight":false,"gpt_icon":0},{"id":"2427063340","title":"福泰制药涨0.86% 股价突破400美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2427063340","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427063340?lang=zh_cn&edition=full","pubTime":"2024-04-15 21:32","pubTimestamp":1713187938,"startTime":"0","endTime":"0","summary":"北京时间2024年04月15日21时32分,福泰制药股票出现异动,股价急速拉升0.86%。截至发稿,该股报399.98美元/股,成交量2.7464万股,换手率0.01%,振幅0.31%。福泰制药股票所在的生物技术行业中,整体涨幅为0.88%。福泰制药公司简介:Vertex Pharmaceuticals 是一家发现和开发用于治疗严重疾病的小分子药物的全球生物技术公司。此外,Vertex 正在评估使用非阿片类药物治疗的针对急性和慢性疼痛的小分子抑制剂,以及 APOL1 介导的肾脏疾病的小分子抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415213218877fcbc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415213218877fcbc6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427764550","title":"美股再现350亿元巨额并购!国内药企抢占IgA肾病药物黄金赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2427764550","media":"华夏时报","top":-1,"share":"https://www.laohu8.com/m/news/2427764550?lang=zh_cn&edition=full","pubTime":"2024-04-13 07:03","pubTimestamp":1712962997,"startTime":"0","endTime":"0","summary":"本报(chinatimes.net.cn)记者胡金华 上海报道在全球资本市场并购业务并不活跃的当口,美股一则医药领域巨额并购公告,让国内资本嗅到了新的赛道风口。4月12日,一家名为Vertex Pharmaceuticals(福泰制药,VRTX.US)的千亿美元市值纳斯达克上市公司发布公告,称将以每股65美元的价格,总计约合49亿美元(约合354.54亿元人...","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/O9-9R5LKbsu3NS-cVwGtdnbUswNj1KPKJz-3zskmsIF3UAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/O9-9R5LKbsu3NS-cVwGtdnbUswNj1KPKJz-3zskmsIF3UAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20240413A00LIO00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20240413A00LIO00","is_publish_highlight":false,"gpt_icon":0},{"id":"2426327617","title":"355亿巨额并购,IgA肾病赛道起风了","url":"https://stock-news.laohu8.com/highlight/detail?id=2426327617","media":"蓝鲸财经","top":-1,"share":"https://www.laohu8.com/m/news/2426327617?lang=zh_cn&edition=full","pubTime":"2024-04-12 14:52","pubTimestamp":1712904720,"startTime":"0","endTime":"0","summary":"而在众多细分赛道中,免疫球蛋白A肾病的热度尤为凸显。继去年诺华斥资35亿美元收购Chinook,如今,Vertex决定49亿美元收购Alpine,以扩大其在肾脏和免疫系统疾病领域的布局。这也意味着,主打IgA肾病药物研发的biotech,潜力和价值正在被市场重新评估和认识。眼下,IgA肾病赛道的大风已起,期待新的变革与突破早日到来。从流行病数据来看,IgA肾病具有显著的人种差异。无论是诺华的入局,还是Vertex的溢价收购,均证实了肾科尤其是IgA肾病赛道的巨大潜力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/230393","is_publish_highlight":false,"gpt_icon":0},{"id":"2426117212","title":"隔夜美股全复盘(4.12)| 三大股指盘中持续走高,苹果、英伟达均涨超4%,据报苹果计划全面更新Mac产品线,搭载增强AI功能的M4芯片","url":"https://stock-news.laohu8.com/highlight/detail?id=2426117212","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2426117212?lang=zh_cn&edition=full","pubTime":"2024-04-12 07:30","pubTimestamp":1712878252,"startTime":"0","endTime":"0","summary":"三大股指盘中持续走高,苹果、英伟达均涨超4%,据报苹果计划全面更新Mac产品线,搭载增强AI功能的M4芯片","market":"hk","thumbnail":"https://img7.gelonghui.com/column/2/140.png","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/140.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/718340","is_publish_highlight":false,"gpt_icon":0},{"id":"2426325015","title":"福泰制药涨1.37% 股价突破400美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2426325015","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426325015?lang=zh_cn&edition=full","pubTime":"2024-04-11 21:32","pubTimestamp":1712842333,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日21时32分,福泰制药股票出现波动,股价急速拉升1.37%。福泰制药股票所在的生物技术行业中,整体涨幅为0.23%。此外,Vertex 正在评估使用非阿片类药物治疗的针对急性和慢性疼痛的小分子抑制剂,以及 APOL1 介导的肾脏疾病的小分子抑制剂。消息层面,截至21时32分,《HC Wainwright & Co.:维持Vertex Pharmaceuticals评级,由买入调整至买入评级, 目标价由457.00美元调整至462.00美元。》资讯为影响福泰制药的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112132138767faa6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112132138767faa6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426425725","title":"快讯| 美股三大指数集体高开,道指涨0.17%,纳指涨0.42%。热门中概股开盘多数上涨,哔哩哔哩涨近3%,微博涨超2%,阿里巴巴涨超1%;Alpine Immune涨超36%,获福泰制药49亿美元收购。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426425725","media":"腾讯自选股","top":-1,"share":"https://www.laohu8.com/m/news/2426425725?lang=zh_cn&edition=full","pubTime":"2024-04-11 21:31","pubTimestamp":1712842273,"startTime":"0","endTime":"0","summary":"美股三大指数集体高开,道指涨0.17%,纳指涨0.42%。热门中概股开盘多数上涨,哔哩哔哩涨近3%,微博涨超2%,阿里巴巴涨超1%;Alpine Immune涨超36%,获福泰制药49亿美元收购。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041121270687e7fa1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041121270687e7fa1c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426296581","title":"354亿元!自免系统最大收购案诞生,市场空间广阔","url":"https://stock-news.laohu8.com/highlight/detail?id=2426296581","media":"证券时报e公司","top":-1,"share":"https://www.laohu8.com/m/news/2426296581?lang=zh_cn&edition=full","pubTime":"2024-04-11 21:24","pubTimestamp":1712841867,"startTime":"0","endTime":"0","summary":"4月10日,根据Vertex Pharmaceuticals(福泰制药,以下简称Vertex)发布公告,Vertex 和Alpine Immune Sciences(以下简称Alpine)已签署收购协议,将以约49亿美元(折合人民币354亿)收购生物技术公司Alpine,以获得后者治疗肾脏自身免疫性疾病的药物。这笔交易对Alpine的估值为每股65美元。公开资料显示,Alpine的核心管...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20240411A09NBF00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20240411A09NBF00","is_publish_highlight":false,"gpt_icon":0},{"id":"2426304062","title":"Evercore ISI Group:上调Vertex Pharmaceuticals(VRTX.US)评级,由大市同步调整至优于大市评级, 目标价438.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426304062","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426304062?lang=zh_cn&edition=full","pubTime":"2024-04-11 18:55","pubTimestamp":1712832949,"startTime":"0","endTime":"0","summary":"Evercore ISI Group:上调Vertex Pharmaceuticals(VRTX.US)评级,由大市同步调整至优于大市评级, 目标价438.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404111856008767420b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404111856008767420b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426494232","title":"BUZZ-街景:Vertex斥资49亿美元收购Alpine Immune,扩大产品组合","url":"https://stock-news.laohu8.com/highlight/detail?id=2426494232","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2426494232?lang=zh_cn&edition=full","pubTime":"2024-04-11 18:39","pubTimestamp":1712831973,"startTime":"0","endTime":"0","summary":" 4月11日 - ** Vertex Pharmaceuticals 将以约49.0亿美元现金收购 药物开发商Alpine Immune Sciences ** VRTX 将获得 ALPN 的基因疗法 povetacicept,用于治疗 IgA 肾病,这是一种肾脏自身免疫性疾病。** 券商还认为,如果 povetacicept 的应用范围超出 IgAN,它将成为价值数十亿美元的产品** Jefferies 称这笔交易将进一步加强 VRTX 在肾脏领域的现有地位,并对其另一种实验性药物形成补充。** TD Cowen 称,此次收购具有战略意义,应能在 2027 年开始促进 VRTX 的收入增长。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2426447723","title":"更新版 1-Vertex 制药公司将以 49 亿美元收购阿尔卑斯免疫科学公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2426447723","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2426447723?lang=zh_cn&edition=full","pubTime":"2024-04-11 04:16","pubTimestamp":1712780171,"startTime":"0","endTime":"0","summary":" 路透社4月10日 - Vertex Pharmaceuticals 和Alpine Immune Sciences 周三表示,两家公司将以每股65美元或约49亿美元现金的价格收购疗法开发商Alpine Immune Sciences 。收购完成后,Vertex公司将增加Alpine公司治疗自身免疫性和炎症性疾病的基于蛋白质的免疫疗法产品组合。这项交易已获得 Vertex 公司和 Alpine 公司董事会的批准,预计将于 2024 年第二季度完成。Alpine公司的股票在延时交易中上涨了20%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vrtx.com","stockEarnings":[{"period":"1week","weight":0.0107},{"period":"1month","weight":-0.0496},{"period":"3month","weight":-0.0755},{"period":"6month","weight":0.1194},{"period":"1year","weight":0.2301},{"period":"ytd","weight":-0.0226}],"compareEarnings":[{"period":"1week","weight":0.0079},{"period":"1month","weight":-0.0295},{"period":"3month","weight":0.033},{"period":"6month","weight":0.226},{"period":"1year","weight":0.2452},{"period":"ytd","weight":0.0593}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Vertex Pharmaceuticals Incorporated成立于1989年,是一家全球性生物技术公司。公司致力于发现、开发、生产和商业化用于专业市场严重疾病的小分子药物。公司与一些世界上最大的制药公司、领先的非盈利性疾病研究机构及许多世界上最知名的学术机构都有合作关系。公司有两款产品:KALYDECO和INCIVEK。","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.030934},{"month":2,"riseRate":0.424242,"avgChangeRate":-0.001228},{"month":3,"riseRate":0.424242,"avgChangeRate":-0.020541},{"month":4,"riseRate":0.606061,"avgChangeRate":0.017464},{"month":5,"riseRate":0.5625,"avgChangeRate":0.081844},{"month":6,"riseRate":0.53125,"avgChangeRate":0.029055},{"month":7,"riseRate":0.4375,"avgChangeRate":-0.00753},{"month":8,"riseRate":0.636364,"avgChangeRate":0.053489},{"month":9,"riseRate":0.484848,"avgChangeRate":0.033856},{"month":10,"riseRate":0.515152,"avgChangeRate":-0.002427},{"month":11,"riseRate":0.484848,"avgChangeRate":-0.02156},{"month":12,"riseRate":0.666667,"avgChangeRate":0.078782}],"exchange":"NASDAQ","name":"福泰制药","nameEN":"Vertex Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"福泰制药(VRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供福泰制药(VRTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"福泰制药,VRTX,福泰制药股票,福泰制药股票老虎,福泰制药股票老虎国际,福泰制药行情,福泰制药股票行情,福泰制药股价,福泰制药股市,福泰制药股票价格,福泰制药股票交易,福泰制药股票购买,福泰制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"福泰制药(VRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供福泰制药(VRTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}